To continue using FE Trustnet please choose an edition:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Factsheet

OMW Norway AXA Framlington Health

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Mark Hargraves




Primary Asset Class

Fund Size

NOK 24.13m as at 27-Feb-2015

Downloads ( Underlying )

Unit Name

OMW Norway AXA Framlington Health





Initial Charge


Unit Currency




Annual Charge



NOK 47.22


NOK 47.22

Change (Offer)

1.37 (2.99%)

Unit LaunchDate


Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 15.33 14.10 41.72 65.89 155.55 190.10
Sector 4.21 3.99 6.48 9.39 22.42 25.90

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 47.52 47.07 8.53 4.85 12.22
Sector 5.16 10.14 6.76 -5.30 8.11

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 72.69
Swiss Equities 9.92
UK Equities 6.39
German Equities 2.57
Danish Equities 1.72
Japanese Equities 1.63
Israeli Equities 1.20
Canadian Equities 1.14
French Equities 1.07
Australian Equities 0.73
South African Equities 0.55
Money Market 0.39

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
United States 72.69
Switzerland 9.92
United Kingdom 6.39
Germany 2.57
Denmark 1.72
Japan 1.63
Israel 1.20
Canada 1.14
France 1.07
Australia 0.73
South Africa 0.55
Cash 0.39

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 34.48
Healthcare Services & Enabling Technology / Tools 27.98
Biotech Product 21.20
Devices 15.95
Cash 0.39

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.